Number of eligible people: CDEC discussed the uncertainty in the volume of sufferers with reasonably critical to significant hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific professionals consulted by CADTH indicated that some patients who're labeled as having delicate or average illness might have a intense bleeding phenotype, which https://hemgenix49371.onesmablog.com/the-definitive-guide-to-hemgenix-76666905